To know the impact of COVID-19 On Antinuclear Antibody Test Market 2020 By Product (Reagents & Assay Kits, Systems, Software & Services), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjgrens Syndrome, Scleroderma, Other Diseases), By Technique (ELISA, Immunofluorescence Assay, Multiplex Assay) Forecast to 2025 Market
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027
Antinuclear Antibody Test Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Antinuclear Antibody Test Market place for the forecast 2020– 2025.
On the basis of estimation, the occurrence rate of lupus is 16,000 new cases annually. Lupus impacts mostly females of childbearing age. On the other hand, teenagers, children, and men get lupus too. Most of the individuals having lupus get the disease between 15–44 years of age. As per Arthritis Foundation, almost 1 in 3 individuals aged between 18–64 years suffer from arthritis. The number of people in the US with doctor-detected arthritis is predicted to increase by 49% by 2040.
Scope of The Report:
Antinuclear antibodies are a bunch of autoantibodies created by a person’s immune system when it fails to differentiate between foreign and self particles. ANA (Antinuclear antibody) is also dibbed as FANA (fluorescent antinuclear antibody) and antinuclear antibody screen. Antinuclear antibodies attack the own body cells. Thus, these are dubbed as antinuclear, as these cells target the cells’ nucleus. Antinuclear antibodies react with elements of the body’s own fit cells and lead to signs and symptoms such as muscle & joint pain, organ & tissue inflammation, and fatigue. Antinuclear antibodies test identifies autoantibodies in the blood. An antinuclear antibodies test decides the attendance of antinuclear antibodies in the blood. If a test identifies antinuclear antibodies in an individual’s body, it can mean that the individual has an autoimmune disorder. An antinuclear antibodies test is employed to assist diagnose autoimmune disorders, comprising scleroderma, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome.
The global antinuclear antibody test market can be divided by application, product, region, and technique. By product, the market can be divided into systems, reagents & assay kits, and software & services. The reagents & assay kits section is predicted to add up the biggest market share during the coming period. This is owing to high acceptance of assay kits and reagents in clinic and research settings. By application, the global antinuclear antibody test market can be divided into rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, scleroderma, and others. By technique, the market can be segmented into multiplex assay, immunofluorescence assay, and enzyme-linked immunosorbent assay (ELISA). The ELISA section is predicted to develop at a quick speed during the coming period owing to moderate level of operator skills required and ease of use while performing the test.
Antinuclear Antibody Test Companies:
The major players included in the global antinuclear antibody test market forecast are,
- Alere, Inc.
- Bio-Rad Laboratories
- ZEUS Scientific
- Antibodies, Inc.
- Immuno Concepts
- Erba Diagnostics
- Trinity Biotech plc
- Inova Diagnostics
- Euroimmun AG.
Antinuclear Antibody Test Market Key Segments:
By Product: Reagents & Assay Kits, Systems, Software & Services
By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjgrens Syndrome, Scleroderma, Other Diseases
By Technique: ELISA, Immunofluorescence Assay, Multiplex Assay
Increase In Occurrence Of Autoimmune Disorders To Power The Development Of The Global Antinuclear Antibody Test Market
The global antinuclear antibody test market is expected to develop at a quick speed during the coming period. Increase in occurrence of autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis and rise in acceptance of antinuclear antibodies tests are the primary factors expected to power the global market during the coming period. As per the Lupus Foundation of America, almost 5 million individuals all over the world and an expected 1.5 million individuals in the US are having lupus.
North America Is Predicted To Dominate The Global Market During The Coming Period
By region, the global antinuclear antibody test market can be divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is predicted to dominate the global market during the coming period, after Europe. Supremacy of the two areas is credited to better health care infrastructure, high patient awareness, and attendance of advanced tests. Asia Pacific is predicted to be the quickest developing market in the coming period owing to high occurrence of autoimmune diseases in nations such as China and India.
Market by Regional Analysis
North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa
Interested in this report?
Antinuclear Antibody Test Market 2020 | Opportunity between 2025
Antinuclear Antibody Test Market 2020 By Product (Reagents & Assay Kits, Systems, Software & Services), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjgrens Syndrome, Scleroderma, Other Diseases), By Technique (ELISA, Immunofluorescence Assay, Multiplex Assay) Forecast to 2025
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.